Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

Delayed Data
As of 4:00pm ET
 +5.58 / +8.03%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Ultragenyx Pharmaceutical Inc have a median target of 76.00, with a high estimate of 94.00 and a low estimate of 57.00. The median estimate represents a +1.21% increase from the last price of 75.09.

Analyst Recommendations

The current consensus among 19 polled investment analysts is to Buy stock in Ultragenyx Pharmaceutical Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 22.98%
Growthannually 7.64%


Growthquarterly 9.92%
Growthannually 72.57%
Key to the earnings and sales forecast charts.